Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
about
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitorsBasic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancerAnti-tumor therapy with macroencapsulated endostatin producer cells.Clinical significance of angiogenic factors in breast cancer.Circulating tumor markers in breast cancer: accepted utilities and novel prospects.The relationship between prognostic and predictive factors in the management of breast cancer.Angiostatic treatment of neuroblastoma.Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.Current status of antiangiogenic factors.Angiogenesis in head and neck squamous cell carcinoma.Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells.Vascular endothelial growth factor in ovarian cancer.The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF).Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cellsMicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.Surrogate markers in antiangiogenesis clinical trials.Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel futureThe -553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women.FGF-2 binding to fibrin(ogen) is required for augmented angiogenesisClinical implications of angiogenesis in cancers.Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor levelPrognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancerRelease of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.Role of VEGF and CD44v6 in differentiating benign from malignant ascites.Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study.Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection?Metronomic dosing of chemotherapy: applications in pediatric oncology.Role of angiogenesis in chronic lymphocytic leukemia.Antiangiogenic therapy in human gastrointestinal malignancies.Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancerProduction of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours.Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.Vascular endothelial growth factor and breast cancer risk.Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer.Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patientsA 3D Poly(ethylene glycol)-based Tumor Angiogenesis Model to Study the Influence of Vascular Cells on Lung Tumor Cell Behavior.Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia.
P2860
Q24298832-07F0601B-127A-4CE4-BBD8-7595886364EAQ24804008-E9DC6A18-430A-4A1D-9687-16B165505D37Q28141264-CA83E907-8E4F-4E57-87D7-0E2DBFB4FE91Q33536136-A06F574A-4DDA-434A-B837-91E315CF71AAQ33538444-B585BE8F-49EE-47CF-A4EF-E1566F7D7D0AQ33538453-52CF8D28-2305-43BC-A129-06D21D12F7CDQ33538455-942DE9BA-C84B-4776-A17F-7166962E4EE1Q33664081-84DEAA14-D00B-4BE2-BC29-FA0CF3E3F4A1Q33820267-2A5E58B6-23AA-4FE4-A0F4-B45CFDB84B48Q33962049-B2211AEC-2264-45BF-B6A1-4FCC30060DB7Q34004670-CF160A22-C50E-4EC4-BB29-9700938F65D0Q34048021-0723BD0E-E03A-4AFD-9626-C2F10024974AQ34060079-28819177-53FA-4B03-87AF-48C5886320BAQ34107669-36113C3B-4741-40AF-AF9F-8A1F9223B28FQ34498455-D5D01C3F-29A9-4D11-9F0A-5D88403508E4Q34648726-7EB5FA56-8233-496C-B824-AD5B189A7800Q34826310-2608646D-F656-49F5-9784-D92A24A084ACQ35167925-0C63826B-7C62-4C49-80F8-D2ACA23BF51DQ35640101-0DC84C88-A87E-449E-BEBD-F3F450567251Q35829182-4CD01DBC-E86A-4041-8B09-49DFAB3347C1Q35848527-35FEA345-FE6B-40E6-80EC-ECF0E50E9090Q36012979-A230EE37-6828-456B-A6B5-C880ACCA2427Q36065624-001E3842-C868-48BE-84F4-360372D39672Q36077140-D8655761-624B-4C38-903F-7728E881605BQ36292232-36B828FA-274E-4504-BE12-3C09455F80A9Q36308920-7CB7BCB7-28C6-4815-9D87-01653EB19D89Q36474101-02F24253-54C3-40F1-8489-A6FF636FE52EQ36474130-0529A236-BD5D-4FEC-863E-D8996587C836Q36508092-D6D47FF4-E07B-4A02-821F-111E600385E9Q36533037-97A9CB70-0681-402A-AF15-F884F3B2119BQ36591067-76FB9882-8171-4347-AFCC-E4C0515E4581Q36617353-01A2B1E1-D077-4271-A61A-60B173953C2DQ36617666-0951919A-6906-4AF2-83F1-0E9C1415B5C6Q36617784-81A26BAC-3C9B-4321-BC82-ECFA828F08A5Q36619082-20CDDCBC-2C32-4568-8FC9-B715600B9120Q36643769-D63BAEAF-127B-466C-915B-F5DC3427C65CQ36646431-5B6D1973-04FF-45CC-9653-046D7EA72549Q36649036-84D73C2E-8100-4B17-A1B7-15A305BBA131Q37232931-513732B0-BAAE-4417-ABCC-3E27177B8191Q37352641-0FAAAB80-4CC0-40C3-9967-EA1D7F7904A2
P2860
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Elevated levels of the angioge ...... or in sera of cancer patients.
@ast
Elevated levels of the angioge ...... or in sera of cancer patients.
@en
type
label
Elevated levels of the angioge ...... or in sera of cancer patients.
@ast
Elevated levels of the angioge ...... or in sera of cancer patients.
@en
prefLabel
Elevated levels of the angioge ...... or in sera of cancer patients.
@ast
Elevated levels of the angioge ...... or in sera of cancer patients.
@en
P2093
P2860
P356
P1476
Elevated levels of the angioge ...... or in sera of cancer patients.
@en
P2093
De Pooter C
Pawinski A
Van Oosterom AT
Vermeulen PB
P2860
P2888
P304
P356
10.1038/BJC.1997.368
P407
P577
1997-01-01T00:00:00Z